F.D.A. Advisers Endorse Paxlovid's Benefits as a Covid Treatment
Briefly

A panel of expert advisers to the Food and Drug Administration on Thursday endorsed Paxlovid as a treatment for adults with Covid who are at high risk for progression to severe illness.The move is likely to lead to full approval of the drug, which has been available under emergency use authorization.
Read at www.nytimes.com
[
add
]
[
|
|
]